Status | Study |
Recruiting |
Study Name: KIDCARE (Kawasaki Disease Comparative Effectiveness Trial) Condition: Mucocutaneous Lymph Node Syndrome Date: 2017-01-17 Interventions: Drug: IVIG Subjects randomized |
Recruiting |
Study Name: A Multi-center, Randomized to Compare the Efficacy of IVIG Alone and IVIG Plus High-dose Aspirin in Kawasaki Disease Condition: Kawasaki Disease Date: 2016-10-28 Interventions: Other: IVIG only All patients |
Withdrawn |
Study Name: Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease Condition: Kawasaki Disease Date: 2016-10-24 Interventions: Drug: Canakinumab Other Name: ACZ885 |
Active, not recruiting |
Study Name: Measurement of Antibodies in Adults With a History of Kawasaki Disease Condition: Kawasaki Disease Date: 2016-07-21 Interventions: Other: laboratory biomarker analysis Archived serum samples are analysed for measurement of biomarker NC |
Recruiting |
Study Name: Safety and Vascular Remodelling After BVS Implantation for Stenotic or Occluded Lesions in Children and Young Adults With KD. Condition: Kawasaki Disease Date: 2016-05-05 Interventions: Device: Bioresorbable Vascular Scaffold |
Completed |
Study Name: Different Doses of IVIG for Kawasaki Disease Condition: Kawasaki Disease Date: 2015-05-07 Interventions: Drug: IVIG (1g/kg,once) The KD |
Recruiting |
Study Name: Anakinra and Kawasaki Disease Condition: Kawasaki Disease Children Date: 2015-03-11 Interventions: Drug: Anakinra The dose of Anakinra will be 2mg/kg. If the patient remains febrile (fever >38°C) |
Completed |
Study Name: Multi-center Prospective Randomized Control Trail of High Dose Aspirin in Acute Stage of Kawasaki Disease Condition: Kawasaki Disease Date: 2015-01-05 Interventions: Drug: Aspirin This study was conduct to investigate the ro |
Completed |
Study Name: Epidemiologic Features of Kawasaki Disease in Shanghai From 2008 Through 2012 Condition: Kawasaki Disease Date: 2014-12-08 |
Completed |
Study Name: Infliximab for Kawasaki Disease Patients Resistant to IVIG : a Multicentre, Prospective, Randomised Trial Condition: Kawasaki Disease Date: 2014-09-23 Interventions: Drug: Infliximab The treatment |